If enacted, Montana health plans covering advanced metastatic cancer could not require patients to fail another drug before receiving certain approved treatments.
People with advanced metastatic cancer could receive coverage for certain approved drugs without first trying another drug, if medical and research standards are met.
The proposed cancer-drug coverage rule would also be listed among the insurance requirements for health maintenance organizations and certain self-funded employer plans.
Insurers would not be allowed to require an insured person to try and fail another drug before covering certain cancer drugs. This would cover insurers selling group or individual health plans in Montana that provide coverage for advanced metastatic cancer or related conditions. The drug must be approved by the U.S. Food and Drug Administration. The drug's use must follow cancer-treatment best practices and be supported by peer-reviewed, evidence-based research. A related condition must involve cancer symptoms or treatment side effects that a health care practitioner believes could further harm the patient if untreated. The restriction would apply before the health plan provides coverage for the qualifying prescription drug.
Health maintenance organizations and certain self-funded employer health arrangements would be subject to the proposed cancer-coverage section under their listed insurance rules. The provision lists Montana-authorized health maintenance organizations and self-funded multiple-employer welfare arrangements with an unrevoked certificate of authority. The arrangements would remain subject to the other limits and exceptions in their governing chapters. The self-funded arrangements must have a certificate of authority that has not been revoked.
No hearings or votes scheduled.